RecruitingPhase 2NCT07282912

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Studying Carcinoma of the ampulla of Vater

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yale University
Principal Investigator
Kiran Turaga, MD
Yale University
Intervention
Sequential cytoreductive intervention(procedure)
Enrollment
54 enrolled
Eligibility
18-80 years · All sexes
Timeline
20262028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07282912 on ClinicalTrials.gov

Other trials for Carcinoma of the ampulla of Vater

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the ampulla of Vater

← Back to all trials